2020 AAN Highlights Jak mění malá molekula průběh spinální svalové atrofie?
| Title in English | 2020 AAN Highlights How does a small molecule change the course of spinal muscle atrophy? |
|---|---|
| Authors | |
| Year of publication | 2020 |
| Type | Article in Periodical (without peer review) |
| MU Faculty or unit | |
| Citation | |
| Description | Communication of prof. Servaise on the first results achieved with risdiplam in the treatment of infants with spinal muscular atrophy (SMA) type I was originally accepted into the main program of this year's annual American Academy of Neurology Congress. After the congress had to be moved to virtual space due to the COVID-19 pandemic, it was heard during a webcast broadcast on April 28. |
| Related projects: |